Primary Mediastinal (Thymic) Large B-cell Lymphoma
Showing 1 - 5 of 5
Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Worldwide (drug, biological, radiation)
Recruiting
- Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Cyclophosphamide
- +12 more
-
Birmingham, Alabama
- +187 more
Jan 31, 2023
Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate
Recruiting
- Aggressive Non-Hodgkin Lymphoma
- +8 more
- Polatuzumab Vedotin
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 26, 2023
DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- +6 more
- Axicabtagene Ciloleucel
- +10 more
- (no location specified)
Jan 13, 2023
B-Cell Non-Hodgkin Lymphoma, DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma Trial in Seattle (Acalabrutinib,
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- +7 more
- Acalabrutinib
- Axicabtagene Ciloleucel
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 9, 2022
Diffuse Large B Cell Lymphoma, Primary Mediastinal (Thymic) Large B-cell Lymphoma, Transformed Indolent Lymphoma Trial in Ramat
Unknown status
- Diffuse Large B Cell Lymphoma
- +4 more
- Bendamustine 90 mg/m2 IV on Days 1-2, Cycles 1-6
-
Ramat Gan, Israel
- +1 more
Apr 21, 2019